Charles Schwab Investment Management »

Rapt Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $339k 10k 33.87
2025-09-30 $258k 10k 25.79
2025-06-30 $80k 10k 8.00